Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Neoadjuvant Chemo or Endocrine Therapy in HER2- Breast Cancer
NCT00773695Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2008
- Primary completion
- Nov 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Roche. Started Nov 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00773695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773695.